Results 161 to 170 of about 280,867 (260)
Conference report: Dhara - Vision Ayurveda 2047. [PDF]
Sangle S, Pakhale P, Joshi M, Saggam A.
europepmc +1 more source
Conference report on contractures in musculoskeletal and neurological conditions. [PDF]
Nuckolls GH +22 more
europepmc +1 more source
Augmenting and Assaying Nav1.1 Protein Quantity for Dravet Syndrome Therapy
ABSTRACT Dravet Syndrome (DS) is a developmental and epileptic encephalopathy predominantly caused by heterozygous loss‐of‐function variants in SCN1A, which encodes Nav1.1. Conserved upstream open reading frames (uORFs) in SCN1A were validated to regulate translation in reporter assays, demonstrating the therapeutic viability of increasing Nav1.1 from ...
Aiswarya Saravanan +7 more
wiley +1 more source
Conference Report: Review of Clinical Implementation of Advanced Quantitative Imaging Techniques for Personalized Radiotherapy. [PDF]
Vinogradskiy Y +4 more
europepmc +1 more source
ABSTRACT Gliomas have undergone a profound redefinition over the past decade, transitioning from morphology‐based entities to biologically coherent diseases defined by molecular alterations. The 2021 WHO Classification of Tumors of the Central Nervous System and its 2022 update formalize this shift, establishing integrated diagnosis as the global ...
Maria Guarnaccia, Sebastiano Cavallaro
wiley +1 more source
A Conference Report from Uses of Fantasy in Changing Media Landscapes Seminar
Minna Siikilä
doaj
Asian Community of Glycoscience and Glycotechnology (ACGG) conference report 2023. [PDF]
Hiremath KY.
europepmc +1 more source
Perspectives From an Onconephrology Interest Group: Conference Report. [PDF]
Kitchlu A +5 more
europepmc +1 more source
Safety and Efficacy of GLP‐1 Receptor Agonists in Adults With Epilepsy, Obesity, and Type 2 Diabetes
ABSTRACT Objective Managing obesity in patients with epilepsy is complicated by the weight‐gaining properties of essential antiseizure medications (ASMs) such as valproate and pregabalin. We evaluated the safety and efficacy of initiating glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) in this population.
Hyoshin Son +3 more
wiley +1 more source

